Ridgetech Return on Equity

Ridgetech (RDGT) currently reports a ROE of -36.63%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Ridgetech's ROE history and peer comparisons.

Ridgetech's ROE of -36.63% is higher than the Healthcare sector average of -75.84%. That is roughly 51.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Ridgetech's current -36.63% should be judged against Healthcare norms (sector average: -75.84%) and against RDGT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -36.63%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Ridgetech, and consider following RDGT for alerts when major investors trade the stock.

Ridgetech is classified in the Healthcare sector. On ROE, it currently shows -36.63% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RDGT with unrelated industries.